Delivery Order SPE2DB22D3019-SPE2DB23FK3MS
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,243.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,560,703,374 Simvastatin 40 mg tablets. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,005.88 firm-fixed-price delivery order (SPE2DB20D1004|SPE2DB23FG3J6) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for 4,561,708,082 units of Simvastatin 20 mg tablets. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,131.53 for the supply of 4,562,967,762 units of Simvastatin 20 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of December 4, 2023. This award is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Simvastatin 20 mg tablets. The contract, valued at $14,131.81, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of September 5, 2023 and is a firm fixed-price contract type. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,544.52 Firm Fixed Price Delivery Order provides Simvastatin 20 mg tablets for the DLA Troop Support Medical program, with a period of performance through November 30, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,556,111,069 units of simvastatin 40 mg tablets. The contract, valued at $17,597.79, was issued by the Defense Logistics Agency (DLA) under Delivery Order SPE2DB22FM4W4 and has a completion date of February 1, 2022. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and...
- This federal contract award is for the delivery of 4,556,108,521 units of 20 mg Simvastatin tablets to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 31, 2022 for a ceiling value of $1,275.63. The contract is a firm fixed-price delivery order with an ultimate completion date of February 1, 2022. No set-aside designation was used for this award. The contract is associated with a...
- This federal contract award is for the delivery of 4,564,659,961 tablets of Simvastatin 20 mg to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, and has a ceiling value of $2,565.06. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,562,234,391 tablets of 40 mg Simvastatin, a prescription medication. The contract has a ceiling value of $4,913.76 and a period of performance ending on September 20, 2023. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,746.54 firm fixed-price delivery order contract is for the supply of 4,564,978,157 units of Simvastatin 20 mg tablets. The contract has a ceiling value of $4,746.54 and a completion date of June 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB23FK3MSDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $2,729.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,560,784,924 units of Simvastatin 20 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating an open competition. This award demonstrates Amerisourcebergen Drug Corp's and Cencora, Inc.'s significant role as a critical supplier of essential medications and medical commodities to the U.S. Department of Defense and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/1/23 |